Pharmaceutical

Novo Nordisk invests $4.1bn in manufacturing facility in NC

Novo Nordisk has unveiled a significant investment plan, committing $4.1bn to construct a second fill and finishing facility in Clayton.

Jun 26, 2024 - 04:00
Novo Nordisk invests $4.1bn in manufacturing facility in NC
Novo Nordisk has unveiled a significant investment plan, committing $4.1bn to construct a second fill and finishing facility in Clayton.
Read the original article

Tags:

Previous Article

GSK’s Omjjara gains approval in Japan for myelofibrosis treatment

Next Article

Disappointing Phase 3 Trial Results Cause Merck to Shelve Head and Neck Cancer Drug

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Novo Nordisk acquires Alkermes’s Irish plant to expand manufacturing capacity

Novo Nordisk acquires Alkermes’s Irish plant to expand ...

Dec 14, 2023

Risk adjusted net present value: What is the current va...

Apr 17, 2024

J&Js Rybrevant plus Lazcluze combination gets FDA approval in NSCLC

J&Js Rybrevant plus Lazcluze combination gets FDA appro...

Aug 21, 2024